Early Immune Signature Features, Including TLR2 and TLR4 Expression, Are Associated with Complete Remission After CD19 CAR-T Cell Therapy.
Saved in:
| Title: | Early Immune Signature Features, Including TLR2 and TLR4 Expression, Are Associated with Complete Remission After CD19 CAR-T Cell Therapy. |
|---|---|
| Authors: | Di Iasio, Serena1 (AUTHOR), Di Nunzio, Chiara1,2 (AUTHOR), De Santis, Elisabetta1,3 (AUTHOR), Stella, Concetta1,4 (AUTHOR), Valente, Daniela2,5 (AUTHOR), Salvatore, Dalila1,2 (AUTHOR), Merla, Emanuela2 (AUTHOR), Dell'Olio, Grazia2,3 (AUTHOR), Padovano, Costanzo1,4 (AUTHOR), Colucci, Mattia1,5 (AUTHOR), Bruno, Gaja1 (AUTHOR), Pasculli, Barbara3 (AUTHOR), Caldarelli, Mario4,5 (AUTHOR), Parrella, Paola3 (AUTHOR), Gambassi, Giovanni4,5 (AUTHOR), Cianci, Rossella4,5 (AUTHOR) giovanni.gambassi@unicatt.it, Carella, Angelo M.2 (AUTHOR) rossella.cianci@unicatt.it, Giambra, Vincenzo1 (AUTHOR) |
| Source: | Pharmaceuticals (14248247). May2026, Vol. 19 Issue 5, p671. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14248247 |
|---|---|
| DOI: | 10.3390/ph19050671 |
